Resolution criteria on PolyGram: This market will resolve to “Yes” if Tesla releases a humanoid, bipedal robot (such as Optimus) by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. A qualifying product is a humanoid, bipedal robot intended for consumer use and newly introduced. Non-humanoid robotics, accessories, internal factory deployments, employee-only programs, and partner/enterprise pilots do not qualify. To be considered “released,” the product must be available for purchase by the general public within the timeframe via an official Tesla consumer channel (e.g., tesla.com) with a live checkout or paid preorder/deposit.
PolyGram is an on-chain prediction market where you trade YES or NO outcome shares with real USDC on Polygon. For this market, buy YES if you believe the event will happen, or NO if you think it won't. Your maximum loss is your stake — winning shares pay $1.00 each at resolution. Unlike sportsbooks, there is no house edge: prices are set by supply and demand from other traders and reflect the crowd's real-time probability.
Market outcomes
| June 30 | 2% YES | 98% NO |
| December 31 | 20% YES | 81% NO |
Tesla's stated goal is to release a commercially available humanoid robot called Optimus to the general public by mid-2026. The market requires a genuine consumer product—not a prototype, factory-only deployment, or enterprise pilot—available for purchase through Tesla's official channels with functioning checkout. The 2% implied probability on Polymarket's order book reflects substantial scepticism about this timeline.
Historical precedent suggests caution. Robotics timelines have consistently slipped across the industry; Boston Dynamics' Spot remained in limited commercial availability for years despite earlier commercialisation claims, whilst humanoid robotics companies like Figure AI and 1X Technologies have faced repeated delays moving from demonstration to genuine public release. Tesla's own track record on delivery promises—from the Roadster to Full Self-Driving—shows a pattern of announced dates extending significantly. The engineering challenges of producing a bipedal humanoid at scale for consumer use remain substantial, encompassing battery life, dexterity, safety certification, and manufacturing feasibility.
Near-term catalysts include Tesla's earnings calls and investor updates, where management typically provides production timelines and technical progress updates. Elon Musk's public statements on Optimus deployment have been frequent but vague; recent commentary in late 2024 suggested initial units might reach limited customers in 2025, though "release" under this market's definition requires full public availability. Any announcement of manufacturing partnerships, regulatory approvals, or pre-order openings would likely shift the probability materially. The eighteen-month window to settlement is compressed for a product requiring manufacturing scale-up, supply chain establishment, and consumer distribution infrastructure.
Test to Release is a COVID-19 testing scheme launched in the United Kingdom. The scheme began operating in England on 15 December 2020, and allows travellers required to quarantine upon returning to England to pay privately for a COVID test five days after their arrival. They are then permitted to end their quarantine period immediately if they receive a neg
Resolution is handled by the UMA optimistic oracle on Polygon. A proposer submits the outcome, a two-hour dispute window opens, and if no one stakes a counter-claim the payout is final. Contested outcomes escalate to UMA token-holder voting. Payouts clear in USDC to the winning side.
The mechanics for trading "Will Tesla release Optimus by...?" are the same as any other PolyGram event contract. Each YES share resolves to $1 if the event happens, or $0 if it doesn't. The current price between 0¢ and 100¢ is the market's probability estimate, set live by the order book.
$84K in lifetime turnover and $14K of resting liquidity puts this market in the above the median by volume for tech contracts on PolyGram. Order-book depth is modest — expect a couple of cents of slippage on $1k+ trades.
The market has been open for 8 months — long enough that the order book is mature and price is well-anchored to fundamentals.
Higher-volume markets tend to have tighter spreads and faster price discovery — meaning the displayed YES/NO percentages are more likely to reflect the true crowd-implied probability rather than a single trader's directional view.
Resolution is handled by the UMA optimistic oracle on Polygon. A proposer submits the outcome, a 2-hour dispute window opens, and if uncontested the payout is final. Contested outcomes escalate to UMA token holders.
This prediction market is scheduled to close on 31 December 2026. After the resolving event occurs, settlement typically clears within 24 hours once the UMA optimistic oracle confirms the outcome. All payouts are in USDC on the Polygon network.
To trade on this prediction market, create a free PolyGram account at polygram.ink, deposit USDC via Polygon, and place a YES or NO order on the outcome you believe in. You can learn more on our how-it-works page. Your maximum loss is limited to your stake — there is no leverage or margin.
When the outcome is determined, winning YES shares pay out $1.00 each in USDC, while losing shares pay $0. Settlement is handled by the UMA optimistic oracle on Polygon — a proposer submits the result, a two-hour dispute window opens, and if uncontested, payouts are distributed automatically. You can withdraw your winnings to any Polygon wallet.
Prediction-market positions can lose 100% of staked capital. Outcomes are uncertain by definition — historical accuracy of crowd-implied probabilities is high in aggregate but not for any single market. PolyGram does not provide investment advice. Trade only with capital you can afford to lose.
Regulatory status varies by jurisdiction. Germany, the United States, and most EU countries treat Polymarket-style event contracts under one of three frameworks: financial derivative, gambling product, or unregulated novel asset. Consult local counsel before trading.
Explore more prediction market odds and trading opportunities on PolyGram: